Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Net Income (2016 - 2025)

Historic Net Income for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to -$53.9 million.

  • Wave Life Sciences' Net Income rose 1283.26% to -$53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$121.9 million, marking a year-over-year increase of 1444.79%. This contributed to the annual value of -$97.0 million for FY2024, which is 6867.14% down from last year.
  • As of Q3 2025, Wave Life Sciences' Net Income stood at -$53.9 million, which was up 1283.26% from -$50.5 million recorded in Q2 2025.
  • Wave Life Sciences' 5-year Net Income high stood at $29.3 million for Q4 2024, and its period low was -$61.8 million during Q3 2024.
  • Moreover, its 5-year median value for Net Income was -$37.8 million (2022), whereas its average is -$31.0 million.
  • The largest annual percentage gain for Wave Life Sciences' Net Income in the last 5 years was 27969.78% (2024), contrasted with its biggest fall of 94920.96% (2024).
  • Wave Life Sciences' Net Income (Quarter) stood at -$34.8 million in 2021, then fell by 25.65% to -$43.7 million in 2022, then soared by 62.76% to -$16.3 million in 2023, then skyrocketed by 279.7% to $29.3 million in 2024, then plummeted by 284.09% to -$53.9 million in 2025.
  • Its Net Income was -$53.9 million in Q3 2025, compared to -$50.5 million in Q2 2025 and -$46.9 million in Q1 2025.